Effects of Antithrombin on Persistent Inflammation, Immunosuppression, and Catabolism Syndrome among Patients with Sepsis-Induced Disseminated Intravascular Coagulation

Effects of Antithrombin on Persistent Inflammation, Immunosuppression, and Catabolism Syndrome among Patients with Sepsis-Induced Disseminated Intravascular Coagulation

Persistent inflammation, immunosuppression, and catabolism syndrome (PICS) is a serious condition after critical care. We examined the efficacy of antithrombin, which may attenuate coagulopathy with the control of inflammation, for PICS among patients with sepsis-induced disseminated intravascular c...

Full description

Bibliographic Details
Main Authors:	Naoki Kanda, Hiroyuki Ohbe, Kensuke Nakamura
Format:	Article
Language:	English
Published:	MDPI AG 2023-06-01
Series:	Journal of Clinical Medicine
Subjects:	PICS persistent inflammation DIC coagulopathy antithrombin
Online Access:	https://www.mdpi.com/2077-0383/12/11/3822

Similar Items

Disseminated Intravascular Coagulopathy Is Associated with the Outcome of Persistent Inflammation, Immunosuppression and Catabolism Syndrome
by: Kensuke Nakamura, et al.
Published: (2020-08-01)

Association of antithrombin with development of trauma-induced disseminated intravascular coagulation and outcomes
by: Takeshi Wada, et al.
Published: (2022-12-01)

Antithrombin as Therapeutic Intervention against Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation: Lessons Learned from COVID-19-Associated Coagulopathy
by: Christian J. Wiedermann
Published: (2022-10-01)

The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation
by: Toshiaki Iba, et al.
Published: (2023-05-01)

Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation
by: Toshiaki Iba, et al.
Published: (2017-11-01)

Effects of combination therapy of antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis
by: Takaaki Totoki, et al.
Published: (2024-01-01)

Antithrombin use and mortality in patients with stage IV solid tumor-associated disseminated intravascular coagulation: a nationwide observational study in Japan
by: Kohei Taniguchi, et al.
Published: (2020-09-01)

Impact of Different Treatments for Disseminated Intravascular Coagulation on Patients with or without Biliary Drainage for Severe Biliary Tract Infection
by: Kobayashi M, et al.
Published: (2023-11-01)

Performances of disseminated intravascular coagulation scoring systems in septic shock patients
by: Julie Helms, et al.
Published: (2020-07-01)

Decreased antithrombin activity in the early phase of trauma is strongly associated with extravascular leakage, but not with antithrombin consumption: a prospective observational study
by: Hironori Matsumoto, et al.
Published: (2018-08-01)

Effect of Antithrombin III Administration on the Prognosis of Severe Trauma Patients with Disseminated Intravascular Coagulation
by: Jae Sik Chung, et al.
Published: (2023-05-01)

Disseminated Intravascular Coagulation in Sepsis and Associated Factors
by: Ikhwan Rinaldi, et al.
Published: (2022-10-01)

Prognostic Significance of Antithrombin Activity in Patients with Crimean-Congo Hemorrhagic Fever
by: Mustafa Usanmaz, et al.
Published: (2011-08-01)

Tramadol and Disseminated Intravascular Coagulopathy: A Case Report
by: Hashem Mohammed Mansour
Published: (2014-12-01)

Disseminated intravascular coagulation in pregnancy: New insights
by: Offer Erez
Published: (2022-03-01)

Hemostasis dan Disseminated Intravascular Coagulation (DIC)
by: Ibnu Umar, et al.
Published: (2020-05-01)

Sepsis-induced coagulopathy and disseminated intravascular coagulation
by: Antonino Giarratano
Published: (2022-07-01)

Clinical Criteria for Persistent Inflammation, Immunosuppression, and Catabolism Syndrome: An Exploratory Analysis of Optimal Cut-Off Values for Biomarkers
by: Kensuke Nakamura, et al.
Published: (2022-09-01)

Endotheliopathy in septic conditions: mechanistic insight into intravascular coagulation
by: Takashi Ito, et al.
Published: (2021-03-01)

The antithrombin activity recovery after substitution therapy is associated with improved 28-day mortality in patients with sepsis-associated disseminated intravascular coagulation
by: Toshiaki Iba, et al.
Published: (2023-11-01)

Kasabach-Merritt-like phenomenon in a massive uterine leiomyoma presenting with chronic disseminated intravascular coagulation: A case report
by: Leo Reap, et al.
Published: (2020-10-01)

Overt disseminated intravascular coagulation and antithrombin III predict bleeding and in-hospital mortality in patients undergoing extracorporeal membrane oxygenation
by: Tae Wan Kim, et al.
Published: (2024-04-01)

EXERTIONAL ANGINA AND DISSEMINATED INTRAVASCULAR COAGULATION
by: S.S. Parshina, et al.
Published: (2008-09-01)

Thrombomodulin in disseminated intravascular coagulation and other critical conditions—a multi-faceted anticoagulant protein with therapeutic potential
by: Takashi Ito, et al.
Published: (2019-08-01)

Hirudins : antithrombin anticoagulants/
by: 245873 Stringer, Kathleen A., et al.

The Necessity of Individualized Treatment for Sepsis-Associated Disseminated Intravascular Coagulation by Infected Organ
by: Kobayashi M, et al.
Published: (2022-04-01)

Investigation of the Differences in Antithrombin to Heparin Binding among Antithrombin Budapest 3, Basel, and Padua Mutations by Biochemical and In Silico Methods
by: Réka Gindele, et al.
Published: (2021-04-01)

Resolution of Disseminated Intravascular Coagulation in a Patient with COVID-19 and Associated Sepsis—Induced Neutropenia
by: Pierpaolo Di Micco, et al.
Published: (2021-01-01)

Sepsis-Associated DIC with Decreased Levels of Antithrombin and Fibrinogen is the Target for Combination Therapy with Thrombomodulin Alfa and Antithrombin
by: Hideo Wada, et al.
Published: (2023-01-01)

Antithrombin Activity and Association with Risk of Thrombosis and Mortality in Patients with Cancer
by: Cornelia Englisch, et al.
Published: (2022-12-01)

Disseminated intravascular coagulation as a complication of bursitis: angiogenesis and repetitive bleeding as potential factors for disseminated intravascular coagulation: a case report
by: Taisuke Hamada, et al.
Published: (2021-04-01)

Proposal of Quick Diagnostic Criteria for Disseminated Intravascular Coagulation
by: Hideo Wada, et al.
Published: (2022-02-01)

Incidence, Outcome, and Risk Factors of Cardiovascular Surgery-Associated Disseminated Intravascular Coagulation: A Single-Center Retrospective Study
by: Norihisa Yasuda, et al.
Published: (2022-06-01)

A case of disseminated intravascular coagulation of sepsis that caused extreme‐thrombocytopenia treated at a remote‐island‐hospital
by: Kazuyoshi Takeshita, et al.
Published: (2023-01-01)

Antithrombin activity levels for predicting long-term outcomes in the early phase of isolated traumatic brain injury
by: Masaki Takahashi, et al.
Published: (2022-09-01)

Extracellular Histones Trigger Disseminated Intravascular Coagulation by Lytic Cell Death
by: Yan Zhang, et al.
Published: (2022-06-01)

Disseminated intravascular coagulation in perinatal medicine
by: M. A. Mingalimov, et al.
Published: (2020-04-01)

Antithrombin III: Plasma Activity and Reference Range Among Nigerian Blood Donors
by: Vincent Oluseye Osunkalu, et al.
Published: (2015-01-01)

Disseminated intravascular coagulation in dogs with gastric dilatation-volvulus syndrome
by: I. Uhrikova, et al.
Published: (2013-11-01)

Clinical study of disseminated intravascular coagulation in pregnancy at tertiary care centre - risk factors, complications, management and outcome
by: Sarojini, et al.
Published: (2023-08-01)